This inventor holds 1 USPTO granted patent. Top assignees: Katholieke Universiteit Leuven Ku Leuven Research & Development, Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Daniel Marx
Introduction
Daniel Marx is a notable inventor based in Linz am Rhein, Germany. He has made significant contributions to the field of pharmacology, particularly through his work on MrgX receptor antagonists. His innovative approach aims to address diseases associated with the MrgX2 receptor, showcasing his commitment to advancing medical science.
Latest Patents
Daniel Marx holds a patent related to MRGX receptor antagonists. The invention pertains to a method for preventing or treating diseases or disorders associated with the MrgX2 receptor. It also includes MrgX2 antagonists and their physiologically acceptable salts. Furthermore, the invention encompasses pharmaceutical compositions and dosage forms that incorporate an MrgX2 antagonist. He has 1 patent to his name.
Career Highlights
Throughout his career, Daniel has worked with esteemed institutions such as Rheinische Friedrich-Wilhelms-Universität Bonn and Katholieke Universiteit Leuven (KU Leuven) Research & Development. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.
Collaborations
Daniel has collaborated with notable colleagues, including Christa Müller and Mohamad Wessam Alnouri. These partnerships have further enriched his research endeavors and have played a crucial role in his innovative projects.
Conclusion
Daniel Marx exemplifies the spirit of innovation in the field of pharmacology. His work on MrgX receptor antagonists not only highlights his inventive capabilities but also his dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile